6Dapoigny M, Ahitbol JL, Fraitag B. Efficacy of peripheral kappa agonist fedotozlne versus placebo in treatment of irritable bowel syndrome. A multiceuter dose-response study[J]. Dig Dis Sci, 1995,40(10) : 2244 - 2249. 被引量：1
7Wingate D, Hongo M, Kellow J, et al. Working party report. Disorders of gastrointestinal motility:Towards a new classification [ J ]. J of Gastroenterology and Hepatology, 2002,17 ( Suppl ): 1 - 14. 被引量：1
8Dmssman, DA, Corasziari E, Talley N J, et al . Rome II : The functional gastrointestinal disorders[M]. 2nd ed. McLean, Virginia: Degnon and Associates. 2000. 被引量：1
9Tsubouchi T, Saito T, Mizutani F, et al. Stimulatory Action of Itopride Hydrochlofide on Colonic Motor Activity In Vitro and In Vivo[J]. J Pharmacol Exp Ther,2003, Apt 30 ; [epub ahead of print]. 被引量：1
10Gwee K A, Leong Y L, Graham C, etal .The role of psychological and biological factors in postinfective gut dysfunction [J]. Gut, 1999,44 (3): 400～ 406. 被引量：1
